Resuscitation in the pregnant patient is an uncommon occurrence, estimated at 1 in 30,000 deliveries, yet it is unique in its potential to save not one, but two lives.
A controlled surgical trial of glutamic acid decarboxylase gene therapy, targeting the subthalamic nucleus in advanced Parkinsons's disease, demonstrated statistically significant improvement in motor symptoms off medication in those receiving gene therapy compared with controls.
Carbamazepine has been linked with severe forms of hypersensitivity reactions. As such, genome wide approaches to identify patients-at-risk have become increasingly important.
A composite score that combines age, motor power, and light touch perception can predict recovery of walking with great accuracy in patients with traumatic spinal cord injury.
Seasonal flu and H1N1 vaccines are safe for patients with myasthenia gravis and should be administered.
